Adelphi Values expands to increase payer insight offering

To meet the evolving needs of our clients, Adelphi Values has recruited two additional Directors with extensive experience of working in the EU, US and Asian payer environments. This further increases the capability to help our clients address the needs of public and private payers at the local and national levels.

Jennifer Cook joins from AstraZeneca where she worked as a Global Pricing and Market Access Director, developing payer pricing and market access strategies – shaping evidence for payer value stories and reimbursement.  Graham Foxon joins the business following a number of years in Switzerland at Ferring Pharmaceuticals. Graham brings a wealth of experience of global pricing and reimbursement and has an in-depth understanding of value communication to meet the needs of payers. Graham has substantial experience in developing payer relevant clinical development plans to include health economic deliverables for payer discussions and reimbursement submissions.

“We have always recognised that understanding the evolving payer driven market landscape is a critical requirement when providing multi-perspective insight to our clients, and as such is as a key part of our deliverables,” commented Steve Handley, Vice President and Practice Lead at Adelphi Values. “I am therefore delighted to welcome both Jeni and Graham to the team, as together they will further strengthen our ability to provide a more strategic offering in this critical area of market access.”

The arrival of Jeni and Graham is just one part of the on-going expansion and strengthening of the Value Insight and Communication practice, with recent recruits in the US adding to the global skill set.

Jennifer-Cook-v3_0    Graham-Foxon-v2_0

Related categories

Company news